The Learning Portal will be under maintenance Friday, 28 January from 10PM to 12AM. Portal functionality may be unavailable intermittently during this window.
We apologize for any inconvenience caused during this time.

Regulatory Focus™ > News Articles > Regulatory Manager: Comparing GCP Requirements for Medical Device Clinical Trials in the US and Jap

Regulatory Manager: Comparing GCP Requirements for Medical Device Clinical Trials in the US and Japan

Posted 01 April 2010

The convergence of US and Japanese medical device regulations and practices provides an opportunity to accelerate delivery of innovative medical devices to patients in need of medical treatment. Reciprocal acceptance of Good Clinical Practices (GCPs) would facilitate multinational studies and promote the use of clinical data to support regulatory submissions in multiple countries. The process of regulatory convergence involves first recognizing differences between the regulations and practices of the governments or governing organizations involved.

 

© 2022 Regulatory Affairs Professionals Society.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe